Evidence map›Paper›PMID 41958480›Full record

ArticleChina CDC weekly2026

Integrated Risk Matrix and Borda Count Analysis on Importation Risk Assessment of Nipah Virus Infection - China, 1999-2026.

Weijing Shang, Qiwen Zheng

Abstract read
In one paragraph

Article in China CDC weekly, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Weijing ShangChina National Center for Bioinformation, Beijing, China.
Qiwen ZhengChina National Center for Bioinformation, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

What is already known about this topic?: Nipah virus (NiV) is a highly lethal zoonotic pathogen. Its re-emergence in India in early 2026 has heightened global public health concerns. What is added by this report?: This study systematically assessed the risk of NiV importation into China from five affected countries. India and Bangladesh posed moderate importation risks, whereas Malaysia, the Philippines, and Singapore presented low risks. What are the implications for public health practice?: The findings emphasize that coupling existing defenses with sustained multi-source surveillance and dynamic risk modeling is essential to mitigate risks of stochastic NiV entry.

Indexed as

Borda count methodEmerging infectious diseaseRisk assessmentRisk matrix

Identifiers

PMID41958480
PMCPMC13056502

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.